MedPath

Pontos-Central Venous Pressure and Cardiac Surgery

Completed
Conditions
Central Venous Pressure
Registration Number
NCT03423420
Lead Sponsor
Charite University, Berlin, Germany
Brief Summary

Recent studies indicated the central venous pressure (CVP) as a prognostic marker. Therefore, we retrospectively analyzed the CVP on admission to the intensive care unit (ICU) in cardiac surgery patients regarding its prognostic value for morbidity and mortality.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
5945
Inclusion Criteria
  • In-patients of the Charité Universitätsmedizin Berlin
  • at least 18 years old
  • female or male sex
  • cardiosurgical intervention (OPS 5.35 and 5.36) between 01/06 and 12/13.
  • post-operative monitoring of anesthesiological intensive care unit
Exclusion Criteria
  • previous cardiosurgical interventions during the same hospital stay.
  • incomplete documentation

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
mortalityan average of 30 days

In-Hospital mortality

Secondary Outcome Measures
NameTimeMethod
mortality rate-190 days

mortality rate after 90 days

mortality rate-55 years

mortality rate after 5 years

Renal insufficiency - 2intensive care unit stay, an average of 5 days

dialysis duration

mortality rate-41 year

mortality rate after 1 year

Hospital stayan average of 13 days

Length of hospital stay

ICU readmissionan average of 30 days

Amount of hospital readmissions

mortality rate-2180 days

mortality rate after 180 days

Central venous pressureintensive care unit stay, an average of 5 days

central venous pressure on intensive care unit

ICU stayan average of 5 days

Intensive care unit length of stay

Renal insufficiency - 3intensive care unit stay, an average of 5 days

Urine production

Strokehospital length of stay, an average of 13 days

incidence of strokes

Renal insufficiency - 1intensive care unit stay, an average of 5 days

Incidence of renal insufficiency

mortality rate-33 years

mortality rate after 3 years

Trial Locations

Locations (1)

Charité - Universitaetsmedizin Berlin

🇩🇪

Berlin, Germany

© Copyright 2025. All Rights Reserved by MedPath